The FDA has approved the COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0, a dual-PCR target HIV-1 viral load test from Roche Molecular Diagnostics.

Roche’s Cobas Test for Chlamydia and Gonorrhea Granted 510 (k) Clearance in U.S. February 1, 2012 Multiplex PCR Assay for cobas 4800 system uses self-collected male urine and vaginal swab samples.

The cobas SARS-CoV-2 Duo test combines the standard qualitative result of a traditional SARS-CoV-2 PCR test with a quantitative result, which measures the viral load of a patient suspected of ...

"Roche's new dual-PCR target HIV-1 viral load test is designed to detect current and emerging genomic variants of HIV with increased sensitivity." About the COBAS® AmpliPrep/COBAS® TaqMan® HIV ...

INDIANAPOLIS, Oct. 3, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. availability of a new HIV-1 viral load test based on the company's proprietary dual-target ...

Roche received a FDA CLIA waiver for its rapid point-of-care test to detect and differentiate influenza A virus and influenza B virus, using its cobas Liat PCR System.

The cobas 5800 System is a real-time PCR molecular testing solution that provides excellent performance and value-added utility from a compact footprint. The cobas 5800 System delivers automation, ...